leadership
confidence high
sentiment neutral
materiality 0.90
Medifast Enters Cooperation Agreement with Steamboat Capital, Nominates Two Directors, CEO to Step Down June 1, 2026
MEDIFAST INC
- Medifast (MED) entered a Cooperation Agreement with Steamboat Capital Partners (beneficial owner >5%) on March 19, 2026.
- Medifast will nominate Steamboat designees Parsa Kiai and Jeff Rose as independent directors at the 2026 annual meeting on May 19, 2026.
- Existing directors Jeffrey Brown and Michael Hoer will not stand for reelection at the 2026 annual meeting.
- CEO Dan Chard will step down on June 1, 2026, remaining Chairman; President Nicholas Johnson to succeed as CEO.
- Steamboat agreed to customary standstill and voting provisions through the 2027 annual meeting.